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Abstract
Background: An underlying tenet of the epigenetic code hypothesis is the existence of protein domains that can
recognize various chromatin structures. To date, two major candidates have emerged: (i) the bromodomain,
which can recognize certain acetylation marks and (ii) the chromodomain, which can recognize certain
methylation marks.
Results: The Epc-N (Enhancer of Polycomb-N-terminus) domain is formally defined herein. This domain is
conserved across eukaryotes and is predicted to form a right-handed orthogonal four-helix bundle with extended
strands at both termini. The types of amino acid residues that define the Epc-N domain suggest a role in mediating
protein-protein interactions, possibly specifically in the context of chromatin binding, and the types of proteins in
which it is found (known components of histone acetyltransferase complexes) strongly suggest a role in epigenetic
structure formation and/or recognition. There appear to be two major Epc-N protein families that can be divided
into four unique protein subfamilies. Two of these subfamilies (I and II) may be related to one another in that
subfamily I can be viewed as a plant-specific expansion of subfamily II. The other two subfamilies (III and IV) appear
to be related to one another by duplication events in a primordial fungal-metazoan-mycetozoan ancestor.
Subfamilies III and IV are further defined by the presence of an evolutionarily conserved five-center-zinc-binding
motif in the loop connecting the second and third helices of the four-helix bundle. This motif appears to consist
of a PHD followed by a mononuclear Zn knuckle, followed by a PHD-like derivative, and will thus be referred to
as the PZPM. All non-Epc-N proteins studied thus far that contain the PZPM have been implicated in histone
methylation and/or gene silencing. In addition, an unusual phyletic distribution of Epc-N-containing proteins is
observed.
Conclusion: The data suggest that the Epc-N domain is a protein-protein interaction module found in chromatin
associated proteins. It is possible that the Epc-N domain serves as a direct link between histone acetylation and
methylation statuses. The unusual phyletic distribution of Epc-N-containing proteins may provide a conduit for
future insight into how different organisms form, perceive and respond to epigenetic information.
Background
Cellular DNA is packaged as chromatin, a condensed fiber
composed of nucleosome core particles. Each core particle
comprises 147 base pairs of DNA wrapped nearly twice
around an octomer of histone proteins, which is canoni-
cally defined by an H3/H4 tetramer flanked by two H2A/
H2B heterodimers [1].
The amino- and carboxy-terminal tails of histone proteins
protrude from the core particle into the solvent, and are
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therefore amenable to post-chromatin packaging modifi-
cation. Well known histone modifications include Lys
acetylation, Ser/Thr phosphorylation and Lys/Arg methyl-
ation at N-terminal tails; however, examples of histone
tail ubiquitinylation, SUMOylation, ADP ribosylation,
glycosylation, carbonylation and biotinylation have also
been described. The dynamic composite of these modifi-
cations (the epigenetic state) predicates chromatin struc-
ture, and therefore gene activity, in a manner that is not
yet fully understood. It is generally thought, however, that
acetylation is positively correlated with transcriptional
activation and that methylation is positively correlated
with gene silencing, though reciprocal examples of each
paradigm have been shown (for recent reviews) [2-4].
There are two competing, but not necessarily mutually
exclusive, models for how a cell interprets epigenetic
information. The first is the "histone code" model which
states that histone tail modification, occurring in sequen-
tial, interdependent layers, specifically alters the affinity
for various chromatin associated proteins in a way that
influences downstream function. For example, the his-
tone code is thought to underlie the determination of
bulk chromatin properties such as the formation and
maintenance of heterochromatic and euchromatic
domains [5-7]. A second hypothesis likens histone modi-
fication to commonly known receptor mediated signal
transduction networks [8]. This "signaling network"
model more easily accounts for the apparent degeneracy
amongst certain histone modifications, and suggests that
such modifications serve to confer bistability, robustness
and adaptability to a presumed chromatin based network.
Regardless of operative model, certain proteins must be
able to recognize particular chromatin structures or out-
puts, and capacitating motifs have evolved apparently for
this purpose. Two well-characterized examples are the
bromodomain and the chromodomain. The bromodo-
main, first identified in the Drosophila chromatin remode-
ling protein Brahma, is a left-handed four-helix bundle
that binds selectively to acetyl-lysine [9,10]. It is con-
served amongst eukaryotes, and has been found distrib-
uted into three major protein families: (i) ATP-dependent
chromatin remodeling factors, (ii) histone acetyltrans-
ferases (HATs, e.g., GCN5, PCAF, TAFII250) and (iii) BET
(bromodomain + ET domain) transcriptional regulators.
Bromodomains can occur as a single copy or in duplicate,
and when they occur in tandem, as in TAFII250, they can
bind selectively to diacetylated histone tails with appro-
priately spaced acetyl-lysine moieties [11]. By contrast,
chromodomains comprise histone methylation mark rec-
ognizing motifs defined by three antiparallel β-strands
reinforced with a single cross-strand helix [12]. Chromo-
domains are also conserved across eukaryotes, and have
even been found in two Phycodnaviridae viruses. Like the
bromodomain, the chromodomain has been distributed
into three major protein families, (i) proteins with an
amino-terminal chromodomain followed by a chromo-
shadow domain [Su(var)205], (ii) proteins with a single
chromodomain in conjunction with other non-related
domains (e.g., Polycomb and the S. cerevisiae histone
acetyltransferase Esa1) and (iii) proteins with tandem
chromodomains (CHD1), all of which participate in epi-
genetic events.
The Epc-N (Enhancer of the Polycomb-N-terminus)
domain is defined and described below. The core of this
domain is predicted to be a right-handed orthogonal four-
helix bundle. It is further defined by the presence of β-
strand extensions at both termini, and its conserved, and
therefore PSI-BLAST defining, residues suggest a role in
protein-protein interaction surface formation, possibly in
the context of chromatin binding. The Epc-N domain
occurs across eukaryotes, and two distinct Epc-N-contain-
ing protein families have been identified. Each of these
families is composed of two subfamilies. Members of
three of the four identified subfamilies have already been
evidenced to participate in epigenetic events, most nota-
bly as components of histone acetyltransferase (HAT)
complexes. Two of the four subfamilies (III and IV) are
further defined by the presence of a five-center-zinc-bind-
ing-motif in the loop that connects the second and third
helices of the four-helix bundle. This motif is composed of
a PHD followed by a mononuclear Zn-knuckle, followed
by a PHD-like derivative, which will be referred to as the
PZPM (PHD/Zn-knuckle/PHD motif). The PZPM is also
an evolutionarily conserved translocatable module, and
all proteins studied to date that contain this motif have
been implicated in histone methylation and/or gene
silencing. Therefore, the Epc-N domain emerges as a can-
didate to be another building block in the limited reper-
toire of domains that could have affinity for specific
epigenetic signatures, and a peculiar phyletic distribution
of the four protein families in which it is found seems to
reflect significant discrepancies in how different organ-
isms have evolved to form and interpret epigenetic infor-
mation.
Results
Epc-N domain discovery and annotation
The hint of a conserved sequence common to some of the
proteins described below was first noted by Stankunas et
al. when they cloned the Enhancer of Polycomb E(Pc) gene
from  Drosophila  [13]. Later bioinformatic analyses by
Koonin and colleagues also suggested the possibility of
conserved sequences common to E(Pc) and Lin-49 during
their seminal work on domain accretion [14,15]. At that
time, fewer sequences were available, and it appeared that
there could be two potentially independent modules,
coined EP1 and EP2 [14,15]. However, because of the lessBMC Genomics 2006, 7:6 http://www.biomedcentral.com/1471-2164/7/6
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An alignment of the Epc-N domains from representative sequences of each of the four identified Epc-N protein subfamilies (I- IV) Figure 1
An alignment of the Epc-N domains from representative sequences of each of the four identified Epc-N protein subfamilies (I-
IV). The alignment was constructed as described in the text. Secondary structure is defined by arrows (β-type extended 
strands) and bars (α-helices) and is annotated based on results from Jpred and corroborated by various prediction algorithms 
at the Polish metaserver [52]. The presumed ligands (20 total) of the PZPM found as part of the Epc-N domain in subfamily III 
and IV proteins are as shown.
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PZPMs in humans, C. elegans and A. thaliana Figure 2
PZPMs in humans, C. elegans and A. thaliana. The alignments were constructed by T-coffee and refined manually as necessary. 
All PZPMs found in C. elegans and A. thaliana are shown. For human sequences, at least one representative of each identified 
PZPM family is shown. There are multiple homologs/paralogs in each family except NSD1 that have been omitted for clarity (3 
BRD1-like molecules, 3 Jade-like molecules, 3 AF10-like molecules, 2 GASC1-like molecules). Human sequences are given with 
GenBank accession numbers, C. elegans sequences with wormbase accession numbers, and A. thaliana sequences with chromo-
somal addresses. All identifiers can be used as queries at [30]. The first portion of the PZPM (solid ligand lines) is identified by 
Pfam as a PHD. The remainder of the PZPM (dashed ligand lines) is not identified by Pfam but appears to comprise a previously 
undefined C2HC zinc knuckle or ribbon followed by a PHD-like derivative. It should be noted that the entire domain is con-
served amongst all PZPM proteins, and for functional considerations it should not be viewed as simply a PHD.
Zn Zn
Zn
Zn Zn
BRD1/BRL (III) AAH47508  CCICMDGEC----------QNSNVILF-CD--MCNLAVHQECYGVP--YIPEGQWLCRHCL-QSRARPADCVLCHNKGGAFKKTDDD---RWGHVVCALWIPEVGFANT
JADE (IV) CAE30500       CDVCQSPDG----------EDGNEMVF-CD--KCNICVHQACYGIL--KVPEGSWLCRTCA-L--GVQPKCLLCPKKGGAMKPTRSG--TKWVHVSCALWIPEVSIGSP
AF10 AAT47519            CCVCSDERG----------WAENPLVY-CDGHGCSVAVHQACYGIV--QVPTGPWFCRKCESQERAARVRCELCPHKDGALKRTDNG---GWAHVVCALYIPEVQFANV
AF17 AAA21145            CCVCSDERG----------WAENPLVY-CDGHACSVAVHQACYGIV--QVPTGPWFCRKCESQERAARVRCELCPHKDGALKRTDNG---GWAHVVCALYIPEVQFANV
GASC1 BAB16102           CFIYSEENIEYSPPNAFLEEDGTSLLISCA--KCCVRVHASCYGIPSHEICDG-WLCARC--KRNAWTAECCLCNLRGGALKQTKNN---RWAHVMCAVAVPEVRFTNV
NSD1 AAK92049            CQNC---------------EKLGELLL-CEA-QCCGAFHLECLGLT--EMPRGKFICNEC----RTGIHTCFVCKQSGEDVKRCLLPLCGKFYHEECVQKYPPTVMQNK
                         *                       ::: *    *   .*  * *:    :  * ::*  *          * :*   .  .*         : *  *.   * . : . 
BRD1/BRL (III) AAH47508  VFIEPIDGVRNIPPARWKLTCYLCKQKG------V-GACIQCHKANCYTAFHVT--CAQKAGLYMKMEPVKELTGGGTTFSVRKTAYCDVH
JADE (IV) CAE30500       EKMEPITKVSHIPSSRWALVCSLCNEK-------F-GASIQCSVKNCRTAFHVT--CAFDRGLEMKTI-------LAENDEVKFKSYCPKH
AF10 AAT47519            STMEPIV-LQSVPHDRYNKTCYICDEQGRESKAAT-GACMTCNKHGCRQAFHVT--CAQFAGLLCEEE-------GNGADNVQYCGYCKYH
AF17 AAA21145            LTMEPIV-LQYVPHDRFNKTCYICEETGRESKAAS-GACMTCNRHGCRQAFHVT--CAQMAGLLCEEE-------VLEVDNVKYCGYCKYH
GASC1 BAB16102           PERTQID-VGRIPLQRLKLKCIFCRHR---VKRVS-GACIQCSYGRCPASFHVT--CAHAAGVLMEPDD------WPYVVN----ITCFRH
NSD1 AAK92049            GFRCSL------------HICITCHAANPANVSASKGRLMRCV--RCPVAYHANDFCLAAGSKILASN------SIICPNHFTPRRGCRNH
                              :              *  *            *  : *    *  ::*..  *  .                           *  *
h
u
m
a
n
 
P
Z
P
M
 
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
Zn
Zn
Zn Zn
Zn
At2g31650 ATX1           CNVCHMDEEYENNLFLQCDKCRMMVHAKCYG--ELEPCDGALWLCNLCRPG----------APDMPPRCCLCPVVGGAMKPT-------TDGRWAHLACAIWIPETCLS
At1g05830 ATX2           CNVCHMDEEYENNLFLQCDKCRMMVHTRCYG--QLEPHNGILWLCNLCRPV----------ALDIPPRCCLCPVVGGAMKPT-------TDGRWAHLACAIWIPETCLL
At3g61740 ATX3           CAVCRWVEDWEENKMIICNRCQVAVHQECYG--VSKSQDLTSWVCRACE------------TPDIERDCCLCPVKGGALKPSD------VEGLWVHVTCAWFRPEVGFL
At4g27910 ATX4           CAVCRWVEDWDYNKIIICNRCQIAVHQECYG--ARHVRDFTSWVCKACE------------RPDIKRECCLCPVKGGALKPTD------VETLWVHVTCAWFQPEVCFA
At5g53430 ATX5           CAVCRWVEDWDYNKIIICNRCQIAVHQECYG--TRNVRDFTSWVCKACE------------TPEIKRECCLCPVKGGALKPTD------VETLWVHVTCAWFQPEVCFA
At3g14740                CAVCQSTDGDPLNPIVFCDGCDLMVHASCYGNPLVKAIPEGDWFCRQCLSSKNR---------EKIFSCCLCTTKGGAMKPT-------NDGRWAHITCALFVPEVYFE
At1g77800 (1st)          CDFCCTG----HHQLIVCTSCKATVHKKCYG---LLEDSGKPWLCSWCELENGR--------ADSERPCLLCPKKGGILKPVLSKTENGGPAEFAHLFCSLWMPEVYIE
At1g77800 (2nd)          CDICRRSETI-WNLIVVCSSCKVAVHIDCYK--CAKEST-GPWYCELCAESSSEPSFNFGEKPNSSTECTLCGGTTGAFRKT-------TNGQWVHAFCAEWSLESTF-
                         * :*        : :: *  *   **  **            * *  *               :    * **    * ::             :.*  *: :  *  : 
At2g31650 ATX1           DVKKMEPIDGVNKVSKDRWKLMCTICGVSYGACIQ-------CSNNSCRVAYHPLCARAAGLCVELEND---------------MSVEGEEADQCIRMLSFCKRH
At1g05830 ATX2           DVKKMEPIDGVKKVSKDRWKLLCSICGVSYGACIQNNDADFQCSNNTCRVAYHPLCARAAGLCVEVLSYPTGDHKLADEDRLFLLSMDDDEADQCIRLLSFCKRH
At3g61740 ATX3           NHENMEPAVGLFKIPANSFLKICTICKQTHGSCVH-------CCK--CATHFHAMCASRAGYNMELHC-------------------LEKNGVQRTRKSVYCSFH
At4g27910 ATX4           SEEKMEPAVGILSIPSTNFVKICVICKQIHGSCTQ-------CCK--CSTYYHAMCASRAGYRMELHC-------------------LEKNGQQITKMVSYCAYH
At5g53430 ATX5           SEEKMEPALGILSIPSSNFVKICVICKQIHGSCTQ-------CCK--CSTYYHAMCASRAGYRMELHC-------------------LEKNGRQITKMVSYCSYH
At3g14740                DPEGREGICCSEVLSKR-WKDRCYLCKVRRGCVIE-------CSEMRCKLAFHVTCGLKEDLCIEYRE-------------------GKKSGGIV---VGFCNEH
At1g77800 (1st)          DLKKMEPILNFPGIKETRRKLLCNLCKVKSGACIR-------CCNGTCRTSFHPICAREAGNRLEV------------------------------WGKHGCDTH
At1g77800 (2nd)          RRGQINPVQGMESLAKK--TDNCCVCQRIYGACTK-------CSYGNCQTTFHPSCARSAGFHM--------------------------TGGGKHPHKAYCEKH
                              :       :        *  *    *.  .       *.   *   :*  *.   .  :                                     *  *
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F42A9.2 (PENJAB III)     CNICLDG-DTSNC--------------------------------------NQIVYCD--RCNLSVHQDCYGI--------PFIPEGC--LECRRCGI---SPAGRVN-
Y53G8AR.2 (PENJAB IV)    CDVCRIS-DCDVA--------------------------------------DEMVFCD--MCNTCVHMVCAGI--------EELPDPAEPWKCAKCAH---MGTPCPP-
F54F2.2 Zfp1 (AF10/AF17) CCVCADE-NGWTD--------------------------------------NPLIYCDGENCEVAVHQGCYGI--------QEVPEGE--WFCAKCTK---ASAMMPGS
Y59A8A.2                 CGVCINQRNIVAA--------------------------------------GDFLQCQ--KCGINVHESCYGT--------LPGGSDDASWYCEPCLY---GLTLPPH-
Y48B6A.11 (GASC1-like)   CAVCQYF-QPPHMNAINHTVPNSSRRLIPKWCFSKTDTKKHEDHHEPPPPLDRLLTCS--NCHVTVHSHCCSGGGGGGGDDDDVTSSGEPWRCPRCRNRTDVEIRTTS-
                         * :*    :                                          . :: *.   *   **  * .             .      *  *
F42A9.2 (PENJAB III)     -------CVLCPSTTGAFK-QVD---QKRWVHVLCVIWVDETHFG--------------NTIFMENVQNVEKALHDRR----------ALSCLLCKNRQ--NARMGACI
Y53G8AR.2 (PENJAB IV)    -------CVLCPALGGSMTYSAD---KTQWAHHSCALFIPEIIFE--------------NEELRAPMTSFERVAEERW----------SQMCSVCD------TRQGACV
F54F2.2 Zfp1 (AF10/AF17) INEATFCCQLCPFDYGALK-KTD---RNGWAHVICALYIPEVRFG--------------NVHSMEPVI-LNDVPTDKF----------NKLCYICNEERPNDAKKGACM
Y59A8A.2                 -------CEFCPSRFGAFK-RADI--RGRWAHAICALYTHGVNYA--------------QTHTRCGV-SWEHLDNNAH-------FG-RRTCTACTDK---IARFGIAS
Y48B6A.11 (GASC1-like)   -------CQLCELRGGALIP-CQIGTDSTWAHVACALFNRRAIFDCPNRPGACFVEPSPRQQSETPRMPPRRLSEEYRAELGDLYENSRWECVVCHR-----TDEGLA-
                                * :*    *::    :      *.*  *.::     :               .          .    :               *  *   :. * . 
F42A9.2 (PENJAB III)     QCSETKCTASF---------HVTCARDSGLVMRINETEDG---QVNRFVWCPKH
Y53G8AR.2 (PENJAB IV)    TCSWVDCEETY---------HVCCALRAGMTVRIQEVPNDPEHNVTRVTYCHKH
F54F2.2 Zfp1 (AF10/AF17) SCNKSTCKRSF---------HVTCAQRKGLLCEEGAISRN----VKYCGYCENH
Y59A8A.2                 RCESGMCKEYL---------HVTCAQKLGLLVDETDDND-TEIAVMRYFFCKKH
Y48B6A.11 (GASC1-like)   PCVL--CIEEQATTSLPTLAHVTCARRVGFVCEVRDYPRG----V--VMICHKH
                          *    *             ** **   *:              *     * :*
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complete repertoire of available sequences at that time,
these domains could not be precisely defined. With many
more sequences in hand, it is now clear that EP1 and EP2
always co-occur to form a single domain, which will be
referred to simply as Epc-N (below).
Here, the Epc-N domain was initially recognized during
an analysis of a family of plant proteins containing an
unusual Agenet domain derivative (Perry and Kleckner,
unpublished data). Pfam [16] and SMART [17] database
searches returned no additional domain architecture
information for one of the members of this family, [ref |
NP_914427] from the rice Oryza sativa; however, a simple
BlastP analysis identified a segment of sequence ~100
amino acid residues in length that was conserved amongst
a group of otherwise seemingly unrelated sequences,
including some from metazoans [18,19]. Using this seg-
ment as a query, a PSI-BLAST search of the non-redundant
protein database (inclusion threshold E = 0.005) con-
verges after the eighth iteration and retrieves over 300
sequences [20]. None of the above threshold hits
appeared to be false positive identifications, and a few
additional candidate sequences were extracted by manual
inspection of the below threshold sequences retrieved by
the search. The domain was delimited by the presence of
divergent low complexity loops at either end, that in some
instances led either to previously identified domains or to
the N-terminus of the protein. Two major protein fami-
lies, that could be split into four distinct protein sub-
families (I-IV) could be identified (below), some of which
had additional features proximal to the Epc-N domain
that appeared conserved amongst subfamily members,
but not amongst all members of the superfamily. The core
elements conserved across the superfamily are shown in a
manually constructed [with consideration of all PSI-
BLAST pairwise alignments and Jpred [21] predicted sec-
ondary structure] composite of ClustalW and T-coffee
alignments of 20 representative sequences (Figure 1)
[22,23]. A current list of Epc-N domain containing
sequences, complete with Pfam annotation statistics for
the previously identified co-occurring domains is availa-
ble [see Additional file 1]. The Jpred secondary structure
consensus of the Epc-N core suggests that it comprises two
short extended strands, followed by four helices, and
finally, an additional extended strand. Two of the four
subfamilies (III and IV) are further characterized by the
presence of the predicted PZPM in the loop connecting
the second and third helices (below). Additional immedi-
ately obvious conserved features include several aromatic
amino acid residues distributed throughout the domain
(in a linear sequence sense), plus an acidic region at the N-
terminus of the first helix and a basic region at the C-ter-
minus of the fourth helix.
The five-center-zinc-binding motif of subfamily III and IV 
Epc-N domains
As noted above, Epc-N subfamilies III and IV are further
defined by the presence of a predicted PZPM (PHD-Zn
knuckle-PHD-like motif) within the loop connecting the
second and third helices of the canonical domain (Figures
1 and 2). As suggested, the first portion of this motif is a
statistically verifiable PHD (plant homeodomain) (Pfam
E ≤ 1.4e-06 in all cases). However, manual inspection of an
alignment of a number of subfamily III and IV sequences
indicated the presence of additional conserved, poten-
tially zinc binding residues. Since zinc binding motifs are
defined by coordinating residue type and position but
typically not by specifics in connecting sequence, they can
be difficult to define by algorithm. Also, the canonical
PHD at the beginning of the motif will not allow a PSI-
BLAST search to converge with the entire domain. There-
fore, a conservative approach was taken to identify which
proteins in humans, the nematode Caenorhabditis elegans
and model plant Arabidopsis thaliana contained the entire
PZPM.
A PSI-BLAST search (E = 0.001) with the PZPM of human
BRD1 [gb | AAH47508] was restricted to the first iteration
of human sequences and returned 333 candidates that
were analyzed manually for the presence of the entire
domain. An alignment with a representative from each
protein family is shown in Figure 2A. The alignment sug-
gests that the entire PZPM comprises the verified PHD,
followed by a C2HC knuckle/ribbon not described previ-
ously, which is followed by a PHD-like derivative. It
should be noted that the PHD-like derivative is not iden-
tified by algorithm analysis of any sequence as a statisti-
cally significant PHD, and that the eighth ligand is an
evolutionarily conserved and motif-defining histidine res-
idue. Five groups of proteins in humans were found to
contain the PZPM: (i) members of Epc-N subfamily III,
(ii) members of Epc-N subfamily IV, (iii) mixed lineage
leukemia (MLL) proteins (trithorax homologs) including
AF10, AF17 and MLLT6, (iv) Jumonji transcription factors
including GASC-1 and (v) NSD1, the nuclear receptor
binding SET [Su(var), Enhancer of zeste, Trithorax]
domain protein.
An analogous search restricted to C. elegans sequences was
performed using the PZPM of F42A9.2 [gb | AAB03164]
(the C. elegans Epc-N subfamily III protein) as the query.
Proteins similar to those in humans were found in this
organism with the exception that NSD1 is not found but
instead there is a potentially related protein with simpler
domain architecture (below) (Figure 2B). Interestingly,
the PZPM is retained in higher plants, but not as part of an
Epc-N domain. The same human BRD1 PZPM sequence
fragment used above was presented as a query to the Ara-
bidopsis  genome WU-BLAST server (E = 0.001), whichBMC Genomics 2006, 7:6 http://www.biomedcentral.com/1471-2164/7/6
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returned only Trithorax homologs and two other pre-
dicted proteins of unknown function (Figures 2C and 3B).
It should be noted that the entire PZPM is conserved
across all Epc-N subfamily III and IV proteins, as well as in
the other described proteins. Therefore, for functional
considerations, it should not be viewed as simply a PHD,
but as a single, large, evolutionarily translocatable unit
that happens to exist as a subdomain in Epc-N subfamily
III and IV proteins.
Domain architectures of Epc-N and PZPM containing 
proteins
As alluded to above, Epc-N containing proteins can be
divided into two major families (based on the presence or
absence of the PZPM), each with two subfamilies.
Domain architecture diagrams of the four identified Epc-
Domain architecture diagrams Figure 3
Domain architecture diagrams. (a) Domain architecture of Epc-N-containing proteins. (b) Domain architecture of PZPM-con-
taining proteins. All diagrams are approximately to scale.
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N domain containing protein subfamilies are shown in
Figure 3A. All Epc-N domain containing proteins are pre-
dicted by PSORT [24] to be nuclear, most contain known
chromatin-associated domains, and they range in length
from ~400 ([emb | CAB96695] from P. vivax) to over
3200 ([gb | AAS64921], RHINOCEROS, from D. mela-
nogaster) amino acid residues [25]. Epc-N subfamily I pro-
teins are characterized by C-terminal Epc-N domain
followed by a coiled-coil domain at the extreme C-termi-
nus of the polypeptide. Subfamily I can be further subdi-
vided into two groups based on the presence (a) or
absence (b) of the aforementioned Agenet domain deriv-
ative closer to the N-terminus. Subfamily II proteins are
characterized by an N-terminal Epc-N domain and a C-
terminal Epc-C (Enhancer of the polycomb C-terminal)
domain. This subfamily can also be subdivided into two
groups (a) and (b); however, to date a (b) protein has
only been found in Drosophila (below). Though they have
distinct domain architectures, subfamily I can be viewed
as a plant lineage-specific expansion of subfamily II.
As described above, Epc-N subfamilies III and IV are
defined by the presence of a PZPM between the second
and third helices of the canonical Epc-N domain. Sub-
families III and IV are related in as much as the N-terminal
positioning of the PZPM-containing Epc-N domain, and
the periodic occurrence of AT-hook motifs. These sub-
families likely arose from duplication events in a primor-
dial fungal-metazoan-mycetozoan ancestor. The
difference between these subfamilies is that subfamily III
members are further defined by the presence of a bromo-
domain (an acetyl-lysine binding four helix bundle) adja-
cent and C-terminal to the Epc-N domain followed by a
low complexity region leading up to a PWWP domain at
the C-terminus. In addition, there is a C2H2 zinc finger at
the N-terminus of select subfamily III proteins (below).
By contrast, subfamily IV proteins contain only the PZPM-
Epc-N domain followed by a variable length stretch of low
complexity sequence.
Domain architecture diagrams of PZPM-containing pro-
teins are shown in Figure 3B. As defined above, there are
five groups of PZPM proteins in humans: (i) members of
Epc-N subfamily III, (ii) members of Epc-N subfamily IV,
(iii) various MLL proteins, (iv) various Jumonji transcrip-
tion factors, and (v) NSD1. Groups (i) and (ii) are as
described above. Group (iii) members consist of an N-ter-
minal PZPM and a C-terminal coiled-coil, while group
(iv) members are defined by an N-terminal Jumonji
domain with C-terminal PZPM followed immediately by
two copies of a Tudor domain. Finally, NSD1 (v) is a large
protein with an N-terminal PWWP domain followed by a
large undefined stretch of sequence leading up to a PZPM,
a lone PHD, a second PWWP domain, a SET domain and
then a second lone PHD that all occur in rapid succession.
C. elegans PZPM proteins are very similar to those found
in humans, and the respective genes are likely orthologs.
There are Epc-N subfamily III and IV representatives, an
apparent MLL-AF10/AF17 homolog, and an N-terminal
Jumonji domain transcription factor. The major differ-
ences between C. elegans and humans at this level are that:
(i) humans have multiple copies, potentially paralogs, of
each PZPM-encoding gene except NSD1 whereas C. ele-
gans has retained only one copy of each gene and (ii) that
there is no apparent NSD1 in C. elegans but rather a
unique protein (Y59A8A.2) consisting of an N-terminal
PZPM and a C-terminal PHD. Since NSD1 contains lone
PHD motifs in addition to its PZPM, it is possible that
Y59A8A.2 and NSD1 modulate similar functions and that
they are in fact encoded by orthologous genes.
As noted above and discussed below, the PZPM is con-
served in plants, but not as part of an Epc-N domain. The
Arabidopsis genome is completely sequenced, and seven
genes were found to encode for proteins with the PZPM.
Five were trithorax homologs, and two types of domain
architectures were apparent in this group. ATX1 and ATX2
are defined by an Agenet variant (interestingly, the same
variant as that found in Epc-N subfamily 1a proteins), fol-
lowed by a PWWP domain, a phenylalanine-tyrosine rich
domain, the PZPM and finally a C-terminal SET domain.
ATX3, ATX4 and ATX5 are somewhat different and are
defined by a PWWP domain followed by a lone PHD, the
PZPM and the C-terminal SET domain. The other two
PZPM proteins in Arabidopsis feature the PZPM as a stand-
alone motif, one with a single copy and one where it has
been duplicated.
Phyletic distribution of Epc-N domain containing protein 
subfamilies
On analysis of Epc-N proteins at the subfamily level, and
an intriguing species distribution is immediately evident
(Figure 4). Subfamily I is exclusive to plants, subfamily II
is almost universally conserved across eukaryotes (with
the notable exceptions of kinetoplastid and Diplomonad
parasites) and subfamilies III and IV, members of which
contain the PZPM, are found in Fungi/Metazoa and Myc-
etozoa (Subfamily III only) but are conspicuously absent
in plants and Aveolata parasites. Several other unusual
features are observed: (i) there was an inferred evolution-
ary event at the Fungi Ascomycota-Fungi Basidiomycota
split in which the primordial basidiomycote retained a
member of subfamily III but not subfamily IV, and the
primordial ascomycote retained a member of subfamily
IV but not subfamily III, (ii) as described above, the PZPM
found in Epc-N subfamilies III and IV persists in plants,
but not as part of a Epc-N domain, and (iii) the domain
architecture of the subfamily III protein from the chordate
plankton component O. dioica is more similar to those of
Endopterygota (all have retained the N-terminal C2H2 ZnBMC Genomics 2006, 7:6 http://www.biomedcentral.com/1471-2164/7/6
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Phyletic distribution of the Epc-N domain Figure 4
Phyletic distribution of the Epc-N domain. This domain is only found in eukaryotes with PSI-BLAST.
I
II
III
Viridiplantae
    Magnoliophyta (flowering plants)
A. thaliana, O. sativa
Viridiplantae
   Magnoliophyta (flowering plants)
A. thaliana, O. sativa, Z. mays
Fungi/Metazoa
   Chordata
H. sapiens, G. gallus, X. laevis, D. rerio, C. intestinalis
   Endopterygota
D. melanogaster, A. mellifera
   Nematoda
C. elegans, C. briggsae
   Fungi Ascomycota
S. cerevisiae, S. pombe, N. crassa, C. albicans
   Fungi Basidiomycota
C. neoformans, U. maydis
Alveolata
   Apicomplexa 
 P. falcipirum, C. parvum, C. hominis, P. berghei
 Ciliophora
      E. uhligi
Mycetozoa (slime molds)
D. discoideum
All others
Kinetoplastids
Diplomonads
Fungi/Metazoa
   Chordata
H. sapiens, G. gallus, X. laevis, D. rerio, O. dioica
   Endopterygota
D. melanogaster, A. mellifera, A. gambiae
   Nematoda
C. elegans, C. briggsae
   Fungi Basidiomycota
C. neoformans, U. maydis
Mycetozoa (slime molds)
D. discoideum
Alveolata
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Fungi Ascomycota
Kinetoplastids
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IV
Fungi/Metazoa
   Chordata
H. sapiens, G. gallus, X. laevis, D. rerio, C. intestinalis
   Endopterygota
D. melanogaster, A. mellifera
   Nematoda
C. briggsae
   Fungi Ascomycota
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   Fungi Microsporidia
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finger) than it is other Chordata (which have not). Obser-
vation (iii) therefore presents an interesting example of a
lower chordate serving as an evolutionary intermediate
between vertebrates and invertebrates not only at the ana-
tomical level but also at the level of protein structure/
domain architecture.
Data mining for the biological roles of Epc-N proteins
Data has been extracted from cited literature and from
publicly available genomic databases including those
linked to the following websites: [26-30]
Epc-N proteins appear to exist as components of large pro-
tein complexes, typically, histone acetyltransferase (HAT)
complexes (Figure 5). There are not yet any data regarding
subfamily I proteins; however, subfamily II proteins have
been found to be essential in several organisms including
budding yeast, Drosophila and C. elegans, consistent with
their near omnipresence in the preceding phyletic distri-
bution analysis. The Epc-N subfamily II protein of S. cere-
visiae, ELP1, has been shown to be a component of the
NuA4 H4/H2A HAT, the only essential HAT in that organ-
ism [31]. The homologous H. sapiens protein, EPC1, has
also been found in similar complexes (p400/NuA4 and
TIP60) in human cell lines [32,33]. In an apparent func-
tional paradox, heterozygous mutations in a Drosophila
subfamily II gene [E(Pc)] are suppressors of position effect
variegation [Su(var)] and enhancers of mutations in poly-
comb genes, and EPC1 has recently been found in an
additional complex, with Ezh2 (Enhancer of zeste, a SET
domain protein) [13,34,35]. Thus, Epc-N subfamily II
proteins are appear to be directly implicated in basic,
essential epigenetic events that govern both transcrip-
tional activation and repression.
Epc-N subfamily III proteins are immediately connected
to some level of epigenetic regulation by the presence of
their family-defining bromodomains. With respect to sub-
families II and IV, somewhat less is currently known about
subfamily III proteins, but it is known that in humans one
subfamily III protein, BR140, is involved in somatic cell
development while a presumed paralog, BRL, is most
highly expressed in germline tissues [36]. The subfamily
III protein in C. elegans is LIN-49. Like BR140, LIN-49 has
been shown to be involved in somatic cell development,
specifically through the regulation of homeotic gene
Currently available biological data regarding Epc-N-containing proteins Figure 5
Currently available biological data regarding Epc-N-containing proteins.
I
II
III
Currently no data are available.  Subfamilies (a) and (b) are both found in A. thaliana and O. sativa.
IV
H. sapiens: JADE, interacts with the von Hippel-Lindau (VHL) renal tumor suppressor.  Component of the TIP60 H4/H2A HAT complex in kidney cells.
S. cerevisiae: NTO1, knockout is viable.  Strong 2-hybrid interactions with (i) SAS3, the catalytic subunit of the NuA3 H3 HAT complex, which is implicated
  in gene silencing, (ii) UMP1, a protein complex formation chaperone, and (iii) SLM6, a protein of unknown function.
C. elegans: Y53G8AR.2, RNAi phenotype: WT.
D. melanogaster: RHINOCEROS, nuclear protein that regulates Ras pathway genes to restrict epidermal growth factor signaling in the eye.
(a) H. sapiens: EPC1, a component of the p400/NuA4 and TIP60 H4/H2A histone acetyltransferase (HAT) complexes.
S. cerevisiae: EPL1, knockout is homozygous lethal.  Component of the NuA4 H4/H2A HAT complex, the only essential HAT in yeast.
C. elegans: Y111B2A.11, RNAi phenotype: embryonic lethal.
(b) D. melanogaster only [E(Pc)].  Heterozygous mutations are enhancers of mutations in polycomb genes and suppressors of position effect variegation.
                  Homozygous mutations are lethal.  (a) is also found in D. melanogaster.
H. sapiens: BR140, implicated in somatic cell development.  BRL, expressed in germline tissue.
C. elegans: LIN-49, implicated in somatic cell development and homeotic gene expression.  Genetic and regulatory interactions with homeobox transcription
  factors including mab-5, egl-5, lim-6, cog-1.  RNAi phenotype: post-embryonic growth defect, sterile progeny, uncoordinated movement defect.
D. melanogaster: CG1845, strong 2-hybrid interaction with CG16838, an AAA-ATPase protein complex formation chaperone.
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expression [37]. The RNAi knockdown line of LIN-49
shows post-embryonic growth defects, sterile progeny and
uncoordinated movement defects, phenotypes which are
also observed in a naturally occurring mutant in which the
sixteenth ligand (20 ligands total) of the PZPM has been
changed from Cys to Ser, presumably disrupting the motif
[38]. Finally, the subfamily III protein of Drosophila,
CG1845, was shown to have a 2-hybrid interaction with
CG16838, an AAA-ATPase thought to function as a chap-
erone in protein complex assembly-dissolution. Interest-
ingly, the subfamily IV protein in S. cerevisiae, NTO1, also
has a two-hybrid interaction with a protein complex
assembly chaperone, suggesting that this is a bona-fide
property of HAT complex regulation.
As suggested, there is a bit more information available
regarding Epc-N subfamily IV proteins. Subfamily IV pro-
teins do not appear to be essential, and are thus inferred
to take on more specialized roles than subfamily II pro-
teins, whose roles seem to be more basic. The NTO1
knockout is viable, and the RNAi of the subfamily IV tran-
script in C. elegans has a WT phenotype. Subfamily IV pro-
teins have been found associated with two different HATs.
The human protein, JADE (of which there is three iso-
forms), interacts physically with the von Hippel-Lindau
tumor suppressor and the H4/H2A HAT TIP60 in kidney
tissue [39,40]. By contrast, NTO1 has a two-hybrid inter-
action with SAS3, the catalytic subunit of the NuA3 H3
HAT complex, which is involved in gene silencing. NTO1
also has two-hybrid interactions with the protein complex
assembly chaperone UMP1 and SLM6, a protein of
unknown function. Finally, the subfamily IV protein of
Drosophila, RHINOCEROS, regulates Ras pathway genes
to restrict epidermal growth factor signaling in the eye, but
its molecular mechanism is currently unknown [41].
Data mining for the biological roles of non-Epc-N PZPM 
proteins
All currently available data regarding non-Epc-N PZPM
proteins point to a role in histone methylation and gene
silencing (Figure 6). Consistent with this, all human
PZPM encoding genes, including JADE, have emerged as
proto-oncogenes with the exception of BR140 and BRL,
for which there are no data on the subject [42-50]. The
human non-Epc-N PZPM proteins each take on different
but related roles: (i) AF10 has recently been shown to
interact physically with DOT1L36, which methylates
lysine 79 of histone H3, (ii) AF17 has a genetic interaction
with the β-catenin-TCF pathway, (iii) GASC1 and other
Jumonji transcription factors are robust transcriptional
repressors in organogenesis, and (iv) NSD1 is a SET
domain protein that methylates lysine 36 of histone H3
and lysine 20 of histone H4. In C. elegans, the homolog of
AF10/AF17, ZFP1, also has a genetic interaction with the
β-catenin/Wnt developmental pathway, and its loss of
function by RNAi suppresses RNAi activity, strongly indi-
cating a WT role in gene silencing. Less is known about the
other C. elegans genes, Y59A8A.2 and Y48B6A, but they
Currently available biological data regarding non-Epc-N PZPM-containing proteins Figure 6
Currently available biological data regarding non-Epc-N PZPM-containing proteins.
Human
MLL AF10: Physical interaction with hDOT1L, which methylates lysine 79 of histone H3.  Implicated in leukemogenesis.
MLL AF17: Genetic interaction with the β-catenin / T-cell factor pathway.  Implicated in leukemogenesis and colorectal cancer.
GASC1/Jumonji Transcription factors:  Strong transcriptional repressors in organogenesis.  Overexpression linked to esophageal cancer.
NSD1:  SET domain protein, verified role in chromatin methylation.  Implicated in leukemogenesis, Sotos and Weaver syndromes.
F54F2.2/ZFP1: Genetic interaction with β-catenin and MOM2 Wnt developmental regulators.  RNAi phenotype: protruding vulva.
  Loss-of-function by RNAi suppresses RNAi activity, so positively implicated in gene silencing.
Y59A8A.2: RNAi phenotype: WT.
Y48B6A.11/GASC1-like: RNAi phenotype: WT.  Strong 2-hybrid interaction with F27C1.3, a nuclear protein of unknown function.
ATX1: Methylates lysine 4 of histone H3, and activates homeotic gene expression in flower development.
Current Biological Data for non-Epc-N PZPM-containing Proteins from humans, C. elegans and A. thaliana
C. elegans
A. thalianaBMC Genomics 2006, 7:6 http://www.biomedcentral.com/1471-2164/7/6
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have WT RNAi phenotypes, similar to what is observed in
the Epc-N subfamily IV RNAi knockdown line. Finally, in
Arabidopsis, only one PZPM encoding gene, ATX1, has
been studied thus far. ATX1 methylates lysine 4 of histone
H3 and activates homeotic gene expression in flower
development [51]. In sum, non-Epc-N PZPM containing
proteins are clearly involved in homeotic gene expression
and local and global transcriptional repression at least
sometimes as a direct consequence of histone methyla-
tion. To date, no other functions have been assigned to
PZPM proteins.
Structural considerations
Jpred secondary structure analyses strongly indicated that
canonical Epc-N domains (those from subfamilies I and
II, that lack the PZPM) comprise four-helix all-alpha folds
(above). Four-helix all-alpha folds typically form bundles,
which may be right-handed or left-handed, and may have
Structural classification of the Epc-N domain Figure 7
Structural classification of the Epc-N domain. (a) Results from submitting canonical Epc-N domain sequences (those lacking the 
PZPM) to the Polish metaserver [52] for tertiary structure analysis. A 3D-Jury score of 50 or greater is considered a significant 
match. The top three matches for the highest scoring sequences are shown. The subfamily I Epc-N domain from O. sativa 
NP_914427 produced a significant match to the colicin IM7 protein, a right-handed orthogonal four-helix bundle. Note that 
while considered statistically below threshold, all of the other top three candidates from the highest scoring sequences were 
matched to right-handed four-helix bundles. (b) A metaserver-generated alignment between the Epc-N domain of NP_914427 
and the matched colicin IM7 structure PDB 1AYI. (c) Structural diagrams.
C
profsec 2° structure  --EEEEE--EEE--------EE----HHHHHHHHHHHH--------HHHHHHHHHHHHHH----------HHHHHHHH-----HHHHHHHHHHHHHHHHH--------
O. sativa NP_914427  QDYIGHIGTDVEMALDESRVIYDMDSDDEVWVSRWRKLGKDSTSVTDDLFERIMDKFEKLAYSHNCNELTIDQMKELDSDNIPLDTIKVIHDYWQDKRKKKGMPLIRH
                                         * .:  :*.  ::: *:..::***::: ::::* *:: . :       ::    ***   .   ::::  : :  : * * :::
E. coli colicin IM7  ........................DYTEAEFVQLLKEIEKENVAATDDVLDVLLEHFVKITEHPDG-----TDLIYYPSDNRDDSPEGIVKEIKEWRAAN-GKPGFKQ
structure 1AYI    ........................---HHHHHHHHHHHHH-------HHHHHHHHHHHHHH----------HHHHHH---------HHHHHHHHHHHHHH--------
3D-Jury reults from submission of canonical Epc-N domains to the Polish metaserver (www.bioinfo.pl/meta)
O. sativa NP_914427     50.00   1AYI    colicin IM7
                        41.88   1GXGa   colicin IM8
                        41.75   1BXIa   colicin IM9
A. thaliana CAB79979    26.25   1AYI    colicin IM7
                        25.38   1GXGa   colicin IM8
                        24.88   1BXIa   colicin IM9
A. thaliana CAB86009    22.50   1GXGa   colicin IM8
                        22.38   1BXIa   colicin IM9
                        21.00   1AYI    colicin IM7
O. sativa XP_463767     27.62   1AYI    colicin IM7
                        23.00   1BXIa   colicin IM9
                        17.62   1GXGa   colicin IM8
Epc-N subfamily I  query           3D-Jury      PDB            protein
C. elegans NP_499642         30.43   1AYI    colicin IM7
                             30.00   1GXGa   colicin IM8
                             29.43   1BXIa   colicin IM9
P. yoelli yoelli EAA22977    29.57   1GXGa   colicin IM8
                             29.29   1BXIa   colicin IM9
                             23.86   1AYI    colicin IM7
A. mellifera XP_397232       27.71   1BXIa   colicin IM9
                             27.57   1AYI    colicin IM7
                             25.14   1GXGa   colicin IM8
M. grisea EAA55275           32.43   1DF0a   calpain 
                             32.43   1JUOa   sorcin
                             28.71   1F4Oa   grancalcin
Epc-N subfamily II  query                   3D-Jury       PDB            protein
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either an orthogonal or up-and-down helix-to-helix spa-
tial orientation. A commonly known right-handed
orthogonal four-helix bundle is the E/F hand, such as
those found in calmodulin. A commonly known left-
handed up-and-down bundle is the bromodomain,
which, as alluded to above, is found in a whole host of
chromatin-associated proteins, including Epc-N sub-
family III members. In order to glean some evidence of
what type of bundle the Epc-N domain might form,
canonical Epc-N domains (those from subfamilies I and
II) were submitted to the Polish metaserver [52] for terti-
ary structure homology analysis. The metaserver simulta-
neously submits a query sequence to an entire battery of
threading and three-dimensional profile search algo-
rithms (e.g., 3D-PSSM [53] mGenTHREADER [54],
FUGUE [55], SUPERFAMILY [56] etc.) and then the pro-
gram 3D-Jury adjudicates between conflicting results [57].
All family I and 20 family II Epc-N domains were applied
to the metaserver, and the three highest scoring matches
for the best fit sequences are shown in Figure 7A. A 3D-
Jury score of 50 or greater is considered significant, and
while one does not expect a high scoring hit with a newly
defined domain for which no structures are available, one
Epc-N domain sequence ([ref | NP_914427], from the rice
O. sativa) did produce a match scored at exactly 50.00 to
the colicin immunity protein (IM) 7 from E. coli (Figure
7B). Colicin IM proteins form right-handed orthogonal
four-helix bundles and are characterized by a relatively
short third helix [58]. All of the highest scoring Epc-N
domains were matched to colicin IM proteins with the
exception of the Epc-N domain from the family II protein
of the ascomycote M. grisea, which found lower-scoring
matches to human E/F hand proteins. As stated above, E/
F hands are also right-handed orthogonal four-helix bun-
dles. Also, like other known right-handed four-helix bun-
dles, the third helix of the Epc-N domain is the shortest in
all sequences examined. Finally, there were no matches
(including sub-significant hits) to the bromodomain (a
prominent left-handed four-helix bundle in the PBD) or
any other left-handed bundle for any of the sequences
examined. Therefore, while the evidence is not strong
enough to claim a direct relationship between the Epc-N
domain and colicin IM proteins, the available data do sug-
gest that the core of the domain is likely a right-handed
orthogonal four-helix bundle. The rest of the domain
comprises beta structures at either end of the linear
sequence that are expected to be in proximity to one
another given the structure of a four-helix bundle. Of
course, these computational results will need to be veri-
fied experimentally, but a diagram of a right-handed
orthogonal four-helix bundle representation of the Epc-N
domain is provided in Figure 7C, and compared to the
bromodomain and the chromodomain. Again, the bro-
modomain is a left-handed up-and-down four-helix bun-
dle that forms an acetylated chromatin-binding motif
using the indicated conserved residues [10]. By contrast,
the chromodomain comprises three antiparallel extended
β-strands reinforced by a cross-strand helix that forms a
methylated chromatin-binding motif using an aromatic
cage [12]. Interestingly, strikingly similar types of residues
are conserved amongst, and therefore define, Epc-N
domains, suggesting that it also could form a chromatin-
binding motif, but this too will need to be assessed exper-
imentally.
Discussion
From the sum of the analyses described above, the Epc-N
domain defined here emerges as a crucial component of
epigenetic regulation. The Epc-N domain appears to be a
protein-protein interaction module, and can be included
with the bromodomain and the chromodomain in the
small cadre of potential histone code interpreters. Current
evidence suggests that the core of this domain is a right-
handed orthogonal four-helix bundle. Further, it can
occur with a PZPM between the second and third helices,
and the nature and apparent positioning of its conserved
amino acid residues suggests that it may have intrinsic
affinity for chromatin. Several Epc-N-containing proteins
have been directly implicated as components of HAT
complexes (e.g., NuA4 and TIP60 H4/H2A HATs and
NuA3 H3 HAT), but intriguingly all proteins studied with
PZPMs are associated with histone methylation and gene
silencing. Therefore, PZPM-containing Epc-N proteins
may be direct links between histone acetylation and meth-
ylation statuses.
The unusual phyletic distribution of Epc-N containing
proteins likely reflects significant discrepancies in the way
different organisms form, perceive and respond to epige-
netic information. Most eukaryotes for which sequence
information is available appear to retain at least one sub-
family II gene (the notable exceptions are the kineto-
plastid and Diplomonad parasites), and the available
knockout lines are all homozygous lethal. Both of these
observations indicate a rather fundamental role for Epc-N
subfamily II proteins in epigenetic structure formation
and/or recognition. However, the evolutionary peculiari-
ties of the other three subfamilies suggest that the basic
properties of the Epc-N domain can be harnessed for
more specialized functions. For example, plants are strik-
ingly different from all other eukaryotes in that they have
a unique Epc-N subfamily (I, which appears to be a line-
age specific expansion of subfamily II) but lack represent-
atives of two other prominent subfamilies (III and IV).
Plant cells have retained totipotency and the ability to
dedifferentiate, hinting at the presence of epigenetic regu-
latory mechanisms different from those found in other
complex multicellular organisms. Previously identified
differences expected to contribute to these phenomena
include a unique class of HD2-type histone deacetylasesBMC Genomics 2006, 7:6 http://www.biomedcentral.com/1471-2164/7/6
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and an acetylation mark on Lys 20 of H4, which is the site
of a methylation mark in animals and fungi [59,60]. The
irregular distribution of the Epc-N domain proteins in
plants documented here suggests that it may also have a
role in plant-specific epigenetic regulation.
Epc-N subfamily III and IV members apparently partici-
pate in specialized epigenetic processes in Fungi, Metazoa
and Mycetozoa. Some effects in higher organisms includ-
ing those mediated by JADE, BRL and RHINOCEROS
appear to be tissue specific and have localized develop-
mental consequences [36,39-41]. Most organisms that
contain one or more subfamily III proteins also have
retained one or more subfamily IV proteins, so while they
are similar in some sense (and likely arise from the dupli-
cation of a single primordial gene), it is doubtful that their
functions are completely overlapping. This is further evi-
denced by the fact that RNAi of the subfamily III transcript
in C. elegans causes severe phenotypes, while RNAi of the
subfamily IV transcript does not. It is therefore interesting
that Mycetozoa and Fungi Basidiomycota have retained a
subfamily III gene but lack a subfamily IV gene and Fungi
Ascomycota have retained a subfamily IV gene but lack a
subfamily III gene. In budding yeast (an ascomycote), the
subfamily IV protein NTO1 is associated with a non-
essential HAT involved in gene silencing, and therefore its
is likely to play a role in mating-type switching and/or tel-
omere and rDNA maintenance. Thus, the evolutionary
event described here suggests that there exists some funda-
mental and perhaps phylum defining difference between
ascomycotes and basidiomycotes at the level of epigenetic
regulation, possibly related to reproduction or telomere
maintenance.
In summary, exhaustive experimental analyses of the Epc-
N domain and the proteins in which it is found are antic-
ipated to provide significant insight into both organism
and tissue specific differences in epigenetic regulation and
basic universal chromosomal processes.
Conclusion
The Epc-N domain is a functionally uncharacterized glob-
ular domain found in proteins with known roles in epige-
netic processes. This domain appears to be a right-handed
orthogonal four-helix bundle that can accommodate a
predicted five-center-zinc-binding motif (the PZPM)
between its second and third helices. It is possible that this
domain has intrinsic affinity for chromatin and that it
links histone acetylation and methylation statuses.
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